HIGHLIGHTS
- who: DCBLD and collaborators from the Fudan University, China have published the Article: Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker, in the Journal: (JOURNAL)
- what: The authors provide the first report of the effects of DCBLD2 on tumorigenesis, prognosis, immune infiltration, and drug sensitivity in pan-cancer based on a dataset from TCGA. In the study , 39 types of tumors were obtained from the TCGA data.
- how: The above results showed that the expression levels of DCBLD2 gene showed significant differences between tumor tissues and normal tissues in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.